67
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Effect of sample type and storage conditions on Golgi membrane protein 73 stability

ORCID Icon, &
Pages 491-495 | Received 26 Apr 2019, Accepted 25 Aug 2019, Published online: 08 Sep 2019

References

  • Kladney RD, Bulla GA, Guo L, et al. GP73, a novel Golgi-localized protein upregulated by viral infection. Gene. 2000;249(1–2):53–65.
  • Bachert C, Fimmel C, Linstedt AD. Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma. Traffic. 2007;8(10):1415–1423.
  • Gu Y, Chen W, Zhao Y, et al. Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases. Ann Clin Biochem. 2009;46(1):38–43.
  • Kladney RD, Cui X, Bulla GA, et al. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology. 2002;35(6):1431–1440.
  • Iftikhar R, Kladney RD, Havlioglu N, et al. Disease- and cell-specific expression of GP73 in human liver disease. Am J Gastroenterology. 2004;99(6):1087–1095.
  • Liu X, Wan X, Li Z, et al. Golgi protein 73(GP73), a useful serum marker in liver diseases. Clin Chem Lab Med. . 2011;49(8):1311–1316.
  • Wei H, Zhang J, Li H, et al. GP73, a new marker for diagnosing HBV-ACLF in population with chronic HBV infections. Diagn Microbiol Infect Dis. 2014;79(1):19–24.
  • Riener MO, Stenner F, Liewen H, et al. Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology. . 2009;49(5):1602–1609.
  • Ba MC, Long H, Tang YQ, et al. GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review. Int J Clin Exp Pathol. 2012;5(9):874–881.
  • Gao G, Dong F, Xu X, et al. Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma. Int J Clin Exp Pathol. 2015;8(9):11379–11385.
  • Hou SC, Xiao MB, Ni RZ, et al. Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma. Oncol Lett. . 2013;6(4):1152–1158.
  • Wang NY, Wang C, Li W, et al. Prognostic value of serum AFP, AFP-L3, and GP73 in monitoring short-term treatment response and recurrence of hepatocellular carcinoma after radiofrequency ablation. Asian Pac J Cancer Prev. 2014;15(4):1539–1544.
  • Block TM, Comunale MA, Lowman M, et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A. 2005;102(3):779–784.
  • Mao Y, Yang H, Xu H, et al. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut. 2010;59(12):1687–1693.
  • Dong M, Chen Z-H, Li X, et al. Serum Golgi protein 73 is a prognostic rather than diagnostic marker in hepatocellular carcinoma. Oncol Lett. 2017;14(5):6277–6284.
  • Najat D. Prevalence of Pre-Analytical Errors in Clinical Chemistry Diagnostic Labs in Sulaimani City of Iraqi Kurdistan. Szecsi PB, ed. PLoS ONE. 2017;12(1):e0170211.
  • Ellervik C, Vaught J, Preanalytical variables affecting the integrity of human biospecimens in biobanking. Clin Chem. 2015; 61 Jul;6. (7):914–934.
  • Rana SV. No Preanalytical Errors in Laboratory Testing: A Beneficial Aspect for Patients. Ind J Clin Biochem. 2012;27(4):319–321.
  • Clinical and Laboratory Standards Institute. Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline. NCCLS document EP17-A (ISBN 1-56238-551-8) (Vol. 24 No. 34). NCCLS, Wayne, Pennsylvania, USA, 2004.
  • International Organisation for Standardization. ISO 5725-6. Accuracy (trueness and precision) of measurement methods and results. Part 6: use in practice of accuracy values. 1994.
  • Xia Y, Shen H, Zhu Y, et al. A sensitive three monoclonal antibodies based automatic latex particle-enhanced turbidimetric immunoassay for Golgi protein 73 detection. Sci Rep. 2017;7(1):40090.
  • Cuhadar S, Koseoglu M, Atay A, et al. The effect of storage time and freeze-thaw cycles on the stability of serum samples. Biochem Med (Zagreb). 2013;23(1):70–77.
  • Mitchell B, Yasui Y, Li CI, et al. Impact of freeze-thaw cycles and storage time on plasma samples used in mass spectrometry based biomarker discovery projects. Cancer Inform. 2005;1:98–104.
  • Guder WG, Narayanan S, Wisser H, et al. List of analytes; preanalytical variables. Brochure in: samples: from the patient to the laboratory. Darmstadt: GIT Verlag; 1996. Volume 10. ISBN 3-928865-22-6.
  • Gao YC, Yuan ZB, Yang YD, et al. Effect of freeze-thaw cycles on serum measurements of AFP, CEA, CA125 and CA19-9. Scand J Clin Lab Invest. 2007;67(7):741–747.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.